The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertensionFrank Erhard Uschner, Jonel Trebicka, Florian Schueller et al.|Oncotarget|2018Cited by 32
High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinomaSven H. Loosen, Tom Luedde, Frank Tacke et al.|Carcinogenesis|2019Cited by 28
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancerSven H. Loosen, Tom Luedde, Annemarie Breuer et al.|JHEP Reports|2020Cited by 25
Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota ShiftsSreepradha Eswaran, Angela Schippers, Anshu Babbar et al.|International Journal of Molecular Sciences|2021Cited by 2
Front & Back MatterVivi‐Anne Oxelius, Stephan Mühlig, Jens Klotsche et al.|International Archives of Allergy and Immunology|2012Cited by 0